Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Open in API
Filings indexed 857 across all filing types
Latest filing 2026-05-21 Director's Dealing
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - Peter Gunzburg 3 pages 316.8KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y form titled ‘Change of Director's Interest Notice’, detailing a director’s personal share acquisitions and holdings. It is a statutory insider trading disclosure by a company director. This aligns precisely with the ‘Director’s Dealing’ category.
2026-05-21 English
Change of Director's Interest Notice - Peter Gunzburg 3 pages 319.3KB
Director's Dealing Classification · 95% confidence The document is an Appendix 3Y “Change of Director’s Interest Notice” lodged with the ASX under listing rule 3.19A.2, detailing a director’s personal share transactions and interests. This clearly aligns with reporting of insider trades by a director, which falls under the “Director’s Dealing” category (Code: DIRS).
2026-05-18 English
Quarterly Activities Report and Appendix 4C - March 2026 10 pages 647.2KB
Interim / Quarterly Report Classification · 100% confidence The document is an 'ASX Announcement' titled 'Quarterly Activities Report and Appendix 4C' for the quarter ended 31 March 2026. It contains a detailed narrative of business activities, clinical study progress, and financial performance, followed by the standardized 'Appendix 4C' cash flow report required by the ASX. This document constitutes a comprehensive quarterly financial and operational report, fitting the definition of an Interim/Quarterly Report (IR). Q3 2026
2026-04-27 English
Change of Director's Interest Notice - Max Johnston 2 pages 291.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the change (purchase on market), and other related information. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or any other type of corporate filing but specifically reports insider trades by directors. Therefore, it fits the category 'Director's Dealing' (DIRS). The document length and content confirm it is the actual notice, not an announcement or certification. Confidence is high due to clear matching of content and regulatory references.
2026-04-01 English
Change of Director's Interest Notice - Mary Harney 2 pages 290.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares and options, including dates, quantities, and nature of the transaction. The content is focused on reporting a change in a director's personal shareholding interests, which aligns with insider trading or director dealings disclosures. The document length is 3449 characters, which is typical for such notices. There is no financial performance data, earnings information, or management discussion. Therefore, this document fits the category of Director's Dealing (DIRS).
2026-03-29 English
Change of Director's Interest Notice - Peter Gunzburg 3 pages 318.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor a full financial report, but a specific insider trading disclosure.
2026-03-12 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.